查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1577508

心臟病诊断的全球市场

Heart Attack Diagnostics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 179 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球心臟病诊断市场将达到 198 亿美元

全球心臟病诊断市场预计 2023 年为 137 亿美元，预计到 2030 年将达到 198 亿美元，2023-2030 年分析期间复合年增长率为 5.5%。医院最终用途是本报告分析的细分市场之一，预计复合年增长率为 6.1%，到分析期结束时将达到 98 亿美元。在分析期间，诊断中心最终用途细分市场的复合年增长率预计为 5.1%。

美国市场预估成长37亿美元，中国复合年增长率为9.0%

预计 2023 年美国心臟病诊断市场规模将达 37 亿美元。中国作为世界第二大经济体，预计2030年市场规模将达42亿美元，2023-2030年分析期间复合年增长率为9.0%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 2.2% 和 5.6%。在欧洲，德国的复合年增长率预计为 3.4%。

全球心臟病诊断市场—主要趋势和驱动因素总结

为什么心臟科诊断能够改变心血管治疗的游戏规则？

心臟病发作诊断是现代心血管护理的基石，为早期准确检测心肌梗塞 (MI) 提供了重要工具，可以极大地改变患者的治疗结果。但到底是什么让这些诊断如此有影响力，为什么它们在医疗保健中扮演越来越重要的角色？当阻塞限制血液流向心臟，导致组织损伤时，就会发生心臟疾病。及时诊断至关重要，因为溶栓治疗和经皮冠状动脉介入治疗 (PCI) 等救生治疗的有效性取决于早期发现。 「黄金时间」的概念——症状出现后的关键时限——使得临床医生必须获得可靠、快速的诊断工具来指南治疗决策。诊断影像技术来确定心臟问题的存在和严重程度，这些工具的速度和准确性决定了患者是否及时接受适当的治疗，因为这是心臟病诊断中持续技术创新的必要性。地减少长期併发症这些技术在急诊医学和常规临床实践中已变得至关重要。

塑造心臟病诊断市场的新兴趋势是什么？

心臟病诊断市场正在经历尖端创新和临床实践转变的变革时期，旨在改善患者的治疗结果。最重要的发展之一是高灵敏度心肌肌钙蛋白 (hs-cTn) 检测的日益普及。这种敏感性的提高可以更早、更准确地检测到心臟病发作，从而缩短治疗时间并提高预后准确性，特别是对于症状不典型的患者。另一个主要趋势是 POCT（即时检测）设备的广泛使用。 POCT 设备可以在床边甚至在救护车等院前环境中进行快速诊断。这些可携式设备可以在几分钟内提供结果，支援更快的分类并减少对集中实验室测试的依赖，从而正在改变急诊医学。此外，人工智慧（AI）和机器学习在诊断平台中的整合正在彻底改变复杂资料（例如心电图模式和成像结果）的解释，有助于检测人类临床医生可能忽略的微妙迹象，从而带来发现。此外，结合了多种生物标记物（例如利尿钠胜肽和发炎标记物）的多标记物组合也越来越受到关注，因为它们提供了更细緻的心臟健康状况，并有助于区分心臟病和其他心臟病。总而言之，这些趋势使得心臟病诊断变得更快、更准确，并且越来越个人化，反映出心血管治疗中向精准医疗的转变。

新技术如何重新定义心臟病诊断？

科技的突破正在再形成心臟病诊断的格局，使工具比以往任何时候都更有效率、更容易使用、更准确。最有影响力的进步之一是诊断设备的小型化，创建了可携式手持系统，即使在远端或资源有限的环境中，也可以快速提供靠近患者的测试结果。这些设备，包括现场心臟生物标记分析仪和可携式心电图监测仪，无需复杂的实验室设置即可实现即时诊断和治疗决策，从而改变紧急护理。穿戴式科技是该领域的另一场革命，智慧型手錶和健康手环现在可以持续监测心臟活动，并即时提醒使用者和医疗保健提供者可能的心臟病发作症状。此功能对于高风险患者特别有价值，因为它可以对潜在的心臟事件进行主动管理和快速反应。此外，人工智慧 (AI) 可以快速且准确地解读复杂的心臟资料，从而增强超音波心动图、 电脑断层扫描和 MRI 等诊断影像的能力。人工智慧主导的平台可以侦测人眼可能错过的微妙模式和异常，从而实现更快、更可靠的诊断。此外，云端基础的平台和远端医疗整合实现了远距离诊断，使临床医生可以更轻鬆地从几乎任何地方存取和解释测试结果。这些创新不仅提高了心臟病诊断的准确性和可近性，而且彻底改变了心血管护理的提供方式，为更主动、资料主导的患者管理方法铺平了道路。

心臟病诊断市场快速成长的关键驱动因素是什么？

心臟病诊断市场的成长主要受到多种因素的推动，例如技术进步、心血管疾病负担的增加以及快速且易于使用的诊断解决方案的转变。主要成长要素之一是心血管疾病的全球增加，心血管疾病仍然是全球死亡的主要原因。人口老化，加上肥胖、高血压和糖尿病等与生活方式相关的危险因子日益普遍，显着增加了需要可靠诊断工具的患者群体。此外，人们对早期检测和预防重要性的认识不断提高，推动了对先进生物标记检测和非侵入性成像技术的需求，这些技术可以在最早阶段识别心臟病发作。另一个关键驱动因素是就地检验(POCT) 设备的日益普及。 POCT 设备在紧急情况、门诊诊所甚至居家医疗环境中提供快速诊断功能。这些可携式设备满足了快速诊断和开始治疗的需求，减少了医院实验室的压力，并提高了繁忙的急诊室的患者吞吐量。人工智慧驱动的诊断平台和高灵敏度生物标记测试等技术创新透过提高诊断准确性和实现个人化风险评估，进一步推动市场成长。此外，远端医疗和远端监控解决方案的使用正在增加，扩大了心臟病诊断的范围，特别是在传统医疗保健设施有限的农村和服务不足的地区。有利的法律规范和报销政策也鼓励新诊断技术的开发和采用，从而惠及更广泛的患者群体。这些因素加上对研发的持续投资，正在推动市场格局向前发展，并将其确立为不断发展的循环系统治疗的关键组成部分。

受访企业范例（总合35 家）

  • Abbott Laboratories, Inc.
  • ACS Diagnostics
  • Baxter International, Inc.
  • Beckman Coulter, Inc.
  • Canon Medical Systems USA, Inc.
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • HeartBeam
  • Midmark Corporation
  • Philips Healthcare

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP24302

Global Heart Attack Diagnostics Market to Reach US$19.8 Billion by 2030

The global market for Heart Attack Diagnostics estimated at US$13.7 Billion in the year 2023, is expected to reach US$19.8 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$9.8 Billion by the end of the analysis period. Growth in the Diagnostic Centers End-Use segment is estimated at 5.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.7 Billion While China is Forecast to Grow at 9.0% CAGR

The Heart Attack Diagnostics market in the U.S. is estimated at US$3.7 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$4.2 Billion by the year 2030 trailing a CAGR of 9.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.2% and 5.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Global Heart Attack Diagnostics Market - Key Trends and Drivers Summarized

Why Are Heart Attack Diagnostics a Game-Changer in Cardiovascular Care?

Heart attack diagnostics have become a cornerstone of modern cardiovascular care, offering critical tools for the early and precise detection of myocardial infarction (MI), which can significantly alter patient outcomes. But what exactly makes these diagnostics so impactful, and why is their role in healthcare becoming increasingly indispensable? Heart attacks occur when a blockage restricts blood flow to the heart, causing tissue damage that, if not treated promptly, can lead to irreversible damage or death. Timely diagnosis is crucial because the effectiveness of life-saving interventions like thrombolysis and percutaneous coronary intervention (PCI) hinges on early detection. The concept of the “golden hour”—the critical time window immediately following the onset of symptoms—makes it imperative that clinicians have access to reliable and rapid diagnostic tools to guide treatment decisions. Current diagnostic approaches rely on a combination of electrocardiograms (ECGs), cardiac biomarker testing, and imaging techniques to identify the presence and severity of heart damage. The speed and accuracy of these tools are key in determining whether a patient receives appropriate care in time, highlighting the need for continuous innovation in heart attack diagnostics. This ongoing evolution not only improves survival rates but also minimizes long-term complications, making these technologies vital for both emergency and routine clinical practice.

Which Emerging Trends Are Shaping the Heart Attack Diagnostics Market?

The heart attack diagnostics market is undergoing a transformative phase, driven by cutting-edge innovations and shifts in clinical practices aimed at improving patient outcomes. One of the most significant developments is the growing adoption of high-sensitivity cardiac troponin (hs-cTn) assays, which can detect extremely low levels of troponin, a key biomarker for myocardial injury. This enhanced sensitivity allows for earlier and more accurate detection of heart attacks, reducing time-to-treatment and improving prognostic accuracy, especially in patients with atypical symptoms. Another major trend is the proliferation of point-of-care testing (POCT) devices, which enable rapid diagnosis at the bedside or even in pre-hospital settings such as ambulances. These portable devices are transforming emergency care by providing results in minutes, thereby supporting quicker triage and reducing reliance on centralized laboratory testing. In addition, the integration of artificial intelligence (AI) and machine learning in diagnostic platforms is revolutionizing the interpretation of complex data, such as ECG patterns and imaging results, leading to earlier detection of subtle signs that might be overlooked by human clinicians. Moreover, multi-marker panels that combine several biomarkers—such as natriuretic peptides and inflammatory markers—are gaining attention, as they offer a more nuanced view of cardiac health and help differentiate heart attacks from other cardiac conditions. Collectively, these trends are making heart attack diagnostics faster, more accurate, and increasingly personalized, reflecting a shift towards precision medicine in cardiovascular care.

How Are New Technologies Redefining Heart Attack Diagnostics?

Technological breakthroughs are reshaping the heart attack diagnostics landscape, making tools more efficient, accessible, and accurate than ever before. One of the most impactful advancements is the miniaturization of diagnostic devices, which has led to the creation of portable and handheld systems that can deliver rapid test results at the patient’s side, even in remote or resource-limited settings. These devices, which include point-of-care cardiac biomarker analyzers and portable ECG monitors, are transforming emergency care by enabling immediate diagnosis and treatment decisions without the need for complex laboratory setups. Wearable technologies are another game-changer in this space, with smartwatches and health bands now equipped to monitor cardiac activity continuously, alerting users and healthcare providers to potential heart attack symptoms in real time. This capability is particularly valuable for high-risk patients, as it allows for proactive management and faster response to potential cardiac events. Additionally, artificial intelligence (AI) is enhancing the capabilities of diagnostic imaging, such as echocardiograms, CT scans, and MRIs, by enabling rapid and more precise interpretation of complex cardiac data. AI-driven platforms can detect subtle patterns and anomalies that might be missed by human eyes, leading to earlier and more confident diagnoses. Furthermore, cloud-based platforms and telehealth integration are enabling remote diagnostics, making it easier for clinicians to access and interpret test results from virtually anywhere. These technological innovations are not only improving the accuracy and accessibility of heart attack diagnostics but are also revolutionizing the way cardiovascular care is delivered, paving the way for a more proactive, data-driven approach to patient management.

What Are the Key Drivers Behind the Rapid Growth of the Heart Attack Diagnostics Market?

The growth in the heart attack diagnostics market is driven by a variety of factors, primarily fueled by advancements in technology, an increasing burden of cardiovascular diseases, and a shift towards rapid and accessible diagnostic solutions. One of the main growth drivers is the global rise in cardiovascular diseases, which remain the leading cause of death worldwide. The aging population, coupled with the increasing prevalence of lifestyle-related risk factors such as obesity, hypertension, and diabetes, is significantly expanding the patient pool in need of reliable diagnostic tools. Moreover, the heightened awareness of the importance of early detection and prevention is boosting demand for advanced biomarker assays and non-invasive imaging technologies that can identify heart attacks in their earliest stages. Another key driver is the growing adoption of point-of-care testing (POCT) devices, which provide rapid diagnostic capabilities in emergency settings, outpatient clinics, and even home care environments. These portable devices are meeting the need for quicker diagnosis and treatment initiation, reducing the strain on hospital laboratories and improving patient throughput in busy emergency departments. Technological innovations, such as AI-enhanced diagnostic platforms and high-sensitivity biomarker tests, are further propelling market growth by offering improved diagnostic accuracy and enabling personalized risk assessment. Additionally, the rising use of telehealth and remote monitoring solutions is expanding the reach of heart attack diagnostics, particularly in rural and underserved areas where access to traditional healthcare facilities is limited. Favorable regulatory frameworks and reimbursement policies are also encouraging the development and adoption of new diagnostic technologies, making them more accessible to a broader patient base. These factors, combined with ongoing investment in research and development, are driving the heart attack diagnostics market forward, establishing it as a key component in the evolving landscape of cardiovascular care.

Select Competitors (Total 35 Featured) -

  • Abbott Laboratories, Inc.
  • ACS Diagnostics
  • Baxter International, Inc.
  • Beckman Coulter, Inc.
  • Canon Medical Systems USA, Inc.
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • HeartBeam
  • Midmark Corporation
  • Philips Healthcare

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Heart Attack Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cardiovascular Diseases Drives Demand for Heart Attack Diagnostic Solutions
    • Here's the Story: How Growing Awareness of Early Detection Expands the Addressable Market for Heart Attack Diagnostics
    • Increasing Adoption of Point-of-Care Testing Propels Market Growth for Rapid Diagnostic Tools
    • Advancements in Biomarker Identification Strengthen Business Case for High-Sensitivity Cardiac Tests
    • Here's How the Shift Towards Personalized Medicine Generates Opportunities for Advanced Cardiac Diagnostic Platforms
    • Rising Focus on Minimally Invasive Testing Boosts Market Potential for Non-Invasive Imaging Technologies
    • Expansion of Telemedicine and Remote Monitoring Transforms Market Dynamics for Heart Attack Diagnostics
    • Emphasis on Reducing Diagnosis Time in Emergency Settings Sustains Demand for Quick and Accurate Testing Methods
    • Here's How Growing Investments in AI and Machine Learning Drive Innovation in Predictive Cardiac Diagnostic Tools
    • Increasing Use of Wearable Health Devices Enhances Market Scope for Continuous Heart Health Monitoring
    • Emergence of At-Home Testing Kits Unlocks New Market Potential in Consumer-Driven Cardiac Health Management
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Heart Attack Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Heart Attack Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Heart Attack Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Heart Attack Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: USA 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 20: Canada Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Canada Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: Canada 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 23: Japan Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: Japan Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: Japan 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 26: China Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: China Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: China 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Heart Attack Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Heart Attack Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Heart Attack Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Europe 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 35: France Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: France Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: France 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 38: Germany Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Germany Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Germany 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 41: Italy Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Italy Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Italy 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 44: UK Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: UK Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: UK 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 47: Spain Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Spain Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Spain 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 50: Russia Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Russia Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Russia 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 53: Rest of Europe Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Rest of Europe Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Rest of Europe 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Heart Attack Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Heart Attack Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for Heart Attack Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 59: Asia-Pacific Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Asia-Pacific Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Asia-Pacific 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 62: Australia Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Australia Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Australia 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 65: India Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: India Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: India 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 68: South Korea Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: South Korea Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: South Korea 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 71: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Rest of Asia-Pacific Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Rest of Asia-Pacific 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Heart Attack Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Heart Attack Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Latin America 16-Year Perspective for Heart Attack Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 77: Latin America Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Latin America Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Latin America 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 80: Argentina Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Argentina Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Argentina 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 83: Brazil Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Brazil Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Brazil 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 86: Mexico Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Mexico Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Mexico 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 89: Rest of Latin America Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Latin America Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Latin America 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Heart Attack Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Heart Attack Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Middle East 16-Year Perspective for Heart Attack Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 95: Middle East Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Middle East Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Middle East 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 98: Iran Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Iran Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Iran 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 101: Israel Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Israel Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Israel 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 104: Saudi Arabia Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Saudi Arabia Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Saudi Arabia 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 107: UAE Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UAE Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: UAE 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 110: Rest of Middle East Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Rest of Middle East Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Rest of Middle East 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Heart Attack Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 113: Africa Recent Past, Current & Future Analysis for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Africa Historic Review for Heart Attack Diagnostics by End-Use - Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Africa 16-Year Perspective for Heart Attack Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Centers End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION